Economic Burden of Checkpoint Inhibitor Immunotherapy for the Treatment of Non–Small Cell Lung Cancer in US Clinical Practice.
Saved in:
| Title: | Economic Burden of Checkpoint Inhibitor Immunotherapy for the Treatment of Non–Small Cell Lung Cancer in US Clinical Practice. |
|---|---|
| Authors: | Nesline, Mary K.1 (AUTHOR) mary.nesline@omniseq.com, Knight, Tyler2 (AUTHOR), Colman, Sam2 (AUTHOR), Patel, Kayshap3 (AUTHOR) |
| Source: | Clinical Therapeutics. Sep2020, Vol. 42 Issue 9, p1682-1682. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 01492918 |
|---|---|
| DOI: | 10.1016/j.clinthera.2020.06.018 |
